Non-Invasive Kidney Stone Therapy Program

Non-Invasive Kidney Stone Therapy Program

Urology practices and ASCs adding office-based stone treatment without anesthesia.

$4,997 program advisory · device and consumables quoted directly by the manufacturer
Request a proposal

The device

SonoMotion — non-invasive stone treatment system. Intended use per the manufacturer’s current FDA clearance or approval: non-invasive fragmentation of kidney stones. Indications, contraindications and training requirements are set by SonoMotion; ClearLine confirms the current labeling with the manufacturer during the assessment.

What the advisory includes

Clinical and financial case for a non-invasive stone treatment system program at your site
Manufacturer engagement, quote and contract review with SonoMotion or its authorized distributor
Credentialing, training, workflow and reimbursement plan
Go-live checklist and 90-day utilization review

How it works

1
Intake call: volumes, payer mix, current pathway
2
Program assessment and business case
3
Procurement support through contract
4
Launch plan and 90-day review

Who it’s for

Urology practices and ASCs adding office-based stone treatment without anesthesia.

Non-Invasive Kidney Stone Therapy Program — $4,997

Request a proposal

ClearLine Healthcare Consulting is an independent advisor and is not affiliated with or endorsed by SonoMotion. Equipment is purchased from the manufacturer or its authorized distributor under their terms.

Editorial & AI Disclosure